ERBB2 and triple-negative breast carcinoma: Interestingly, we observed the highest percentage of high SAβ-gal positive tumor cells within HER2 positive patient samples (87.5%) whereas the vast majority of triple negative breast cancer (TNBC) samples did not display any SAβ-gal positive tumor cells (88.9%) (Table 3) (Figure 3C a–d).